Flamel Technologies (FLML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FLML | AKBA | ALT | ||
| Company | Flamel Technologies | Akebia Therapeutics | Altimmune Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.06 | 1.6800 | 4.58 | ||
| High | 10.45 | 1.7100 | 4.59 | ||
| Low | 10.00 | 1.6550 | 3.83 | ||
| Latest | 10.39 | 1.6600 | 3.90 | ||
| Change | +0.33 | -0.0100 | -1.15 | ||
| % Change | +3.28% | -0.60% | -22.77% | ||
| Volume | 115,300 | 5,352,000 | 22,528,299 | ||
| 20-Day Average Volume | 98,525 | 3,139,360 | 4,565,800 | ||
| Previous Close | 10.06 | 1.6700 | 5.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 1.5940 | 5.12 | ||
| 20-Day Raw Stochastic | 44.30% | 76.79% | 3.18% | ||
| 20-Day Relative Strength | 47.66 | 41.26 | 37.96 | ||
| Weighted Alpha | -14.90 | -30.00 | -21.60 | ||
| Today's Opinion | N/A | 88% Sell | 16% Sell | ||
| Previous Opinion | N/A | 88% Sell | 56% Buy | ||
| Last Month's Opinion | N/A | 88% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.76% since 12/23/16 | unch since 12/12/25 | -26.00% since 12/12/25 | ||
| Low | 9.73 on 12/29/16 | 1.5900 on 12/15/25 | 3.83 on 12/19/25 | ||
| High | 10.45 on 12/30/16 | 1.7250 on 12/18/25 | 5.50 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | -2.17% since 11/30/16 | +4.40% since 11/19/25 | -15.03% since 11/19/25 | ||
| Low | 9.73 on 12/29/16 | 1.4450 on 12/02/25 | 3.83 on 12/19/25 | ||
| High | 11.22 on 12/05/16 | 1.7250 on 12/18/25 | 6.03 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | -16.21% since 09/30/16 | -41.13% since 09/19/25 | +3.17% since 09/19/25 | ||
| Low | 9.16 on 11/08/16 | 1.4450 on 12/02/25 | 3.68 on 09/30/25 | ||
| High | 13.25 on 10/10/16 | 3.2000 on 10/28/25 | 6.03 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | -3.26% since 06/30/16 | -53.37% since 06/18/25 | -42.48% since 06/18/25 | ||
| Low | 9.16 on 11/08/16 | 1.4450 on 12/02/25 | 2.90 on 06/26/25 | ||
| High | 15.45 on 08/24/16 | 4.0787 on 07/11/25 | 7.73 on 06/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 414,880 | 440,508 | 406,934 | ||
| Shares Outstanding, K | 41,240 | 265,366 | 104,342 | ||
| Annual Sales | 173,210,000 | 160,180,000 | 20,000 | ||
| Annual Net Income | 40,660,000 | -69,410,000 | -95,060,000 | ||
| Last Quarter Sales | 32,090,000 | 58,770,000 | 10,000 | ||
| Last Quarter Net Income | -19,990,000 | 540,000 | -19,010,000 | ||
| 60-Month Beta | 1.46 | 0.31 | -0.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/07/16 | 0.00 on 11/10/25 | -0.21 on 11/06/25 | ||
| Latest Earnings Date | 03/09/17 | 03/12/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | 2.910 on 02/06/17 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.69 | 0.00 | 0.00 | ||